Biogen Inc.

06/10/2026 | Press release | Distributed by Public on 06/10/2026 14:55

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders

On June 9, 2026, Biogen Inc. (the "Company") held its 2026 Annual Meeting of Stockholders. The final voting results for this meeting are as follows:

1. Stockholders elected ten nominees to the Board of Directors to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified, with the votes cast as follows:
Nominee Votes For Votes Against Abstentions Broker Non-Votes
Maria C. Freire

103,033,121

18,790,237

84,064

9,359,127

William A. Hawkins

102,135,204

19,683,098

89,120

9,359,127

Susan K. Langer

103,931,406

17,886,544

89,472

9,359,127

Jesus B. Mantas

101,698,187

20,117,077

92,158

9,359,127

Lloyd Minor

121,220,738

594,000

92,684

9,359,127

Menelas Pangalos

121,130,060

682,983

94,379

9,359,127

Monish Patolawala

120,796,249

1,016,057

95,116

9,359,127

Eric K. Rowinsky

93,569,685

28,216,589

121,148

9,359,127

Stephen A. Sherwin

103,025,923

18,788,272

93,227

9,359,127

Christopher A. Viehbacher

121,127,966

688,051

91,405

9,359,127

2. Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast as follows:
Votes For Votes Against Abstentions
124,551,887 6,627,086 87,576
3. Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:
Votes For Votes Against Abstentions Broker Non-Votes
114,184,816 7,454,737 267,869

9,359,127

Biogen Inc. published this content on June 10, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 10, 2026 at 20:55 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]